Medicina Interna

  • Bibliografía Medicina Interna (actualizado a 21 de abril - 32 referencias)


  1. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. febrero de 2020;395(10223):514-23.

  2. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. abril de 2020;46(4):586-90.

  3. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. abril de 2020;8(4):e21.

  4. An P, Song P, Wang Y, Liu B. Asymptomatic Patients with Novel Coronavirus Disease (COVID-19). Balkan Med J [Internet]. 13 de abril de 2020 [citado 21 de abril de 2020]; Disponible en: http://www.balkanmedicaljournal.org/pdf.php?&id=2206

  5. Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. The Lancet Haematology. abril de 2020;S2352302620301095.

  6. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. marzo de 2020;21(3):335-7.

  7. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 26 de marzo de 2020;m1091.

  8. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 17 de marzo de 2020;323(11):1061.

  9. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 28 de febrero de 2020;NEJMoa2002032.

  10. Liu K, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province: Chinese Medical Journal. febrero de 2020;1.

  11. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. febrero de 2020;S2213260020300795.

  12. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. marzo de 2020;395(10229):1054-62.

  13. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. febrero de 2020;395(10223):497-506.

  14. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 8 de abril de 2020;e38.

  15. Singh AK, Gupta R, Misra A. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. julio de 2020;14(4):283-7.

  16. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med [Internet]. 2 de abril de 2020 [citado 21 de abril de 2020]; Disponible en: http://link.springer.com/10.1007/s11684-020-0767-8

  17. Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Research and Clinical Practice. abril de 2020;162:108142.

  18. Liu W, Li H. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. :29.

  19. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. febrero de 2020;395(10223):507-13.

  20. McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. N Engl J Med. 27 de marzo de 2020;NEJMoa2005412.

  21. Amgalan A, Othman M. Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered Questions. J Thromb Haemost [Internet]. 11 de abril de 2020 [citado 21 de abril de 2020]; Disponible en: http://doi.wiley.com/10.1111/jth.14832

  22. Ryan JJ, Melendres L, Zamanian R, Oudiz R, Chakinala MM, Rosenzweig EB, et al. EXPRESS: Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) Pandemic. Pulm Circ. 30 de marzo de 2020;204589402092015.

  23. National Health Commission (NHC) of the PRC - National Administration of Traditional Chinese Medicine of the PRC. Guidance for Corona Virus Disease 2019. Prevention, Control, Diagnosis and Management [Internet]. 1.a ed. People’s Republic of China: People’s Medical Publishing House; 2020 [citado 20 de abril de 2020]. 136 p. Disponible en: https://www.pmph.com/

  24. Lippi G, Wong J, Henry BM. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Polish Archives of Internal Medicine [Internet]. 31 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: https://www.mp.pl/paim/issue/article/15272

  25. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Journal of Infection. abril de 2020;S0163445320302085.

  26. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of Underlying Diseases in Hospitalized Pa- tients with COVID-19: a Systematic Review and Meta- Analysis. :14.

  27. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost [Internet]. 9 de abril de 2020 [citado 21 de abril de 2020]; Disponible en: http://doi.wiley.com/10.1111/jth.14830

  28. Onder G, Rezza G, Brusaferro S. Relation to COVID-19 in Italy. 2020;2.

  29. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med [Internet]. 13 de marzo de 2020 [citado 21 de abril de 2020]; Disponible en: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184

  30. Li H, Xiang X, Ren H, Xu L, Zhao L, Chen X, et al. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis. Journal of Infection. abril de 2020;S0163445320301626.

  31. Chang D, Mo G, Yuan X, Tao Y, Peng X, Wang F, et al. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. Am J Respir Crit Care Med. 23 de marzo de 2020;rccm.202003-0524LE.

  32. Kamps BS, Hoffmann C, Reference C. Traductora: Anisha Gualani Gualani. :109.